🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Every now and again, I try to recommit to twitter for professional discourse. Here's another go. The promise and peril of using RCTs as a framework for addressing racial disparities in therapeutic inertia. ja.ma/34BbxRi via JAMA Network Open part of JAMA Network

The proportion of screaming kids coming from primary care next door is higher than average. I’m hopeful it’s a marker of vaccination uptake.

Reminder - prevalence (reported here) is not incidence (a rate). Agree with "rare", but the same approach for common conditions could be misleading. Sexual Intercourse With Sudden Cardiac Death in Young Individuals ja.ma/3rcNY9b via JAMA Cardiology part of JAMA Network

Sweet merciful...why even have prior auth processes, appropriate use, etc, if you're just gonna cave on crap like this. US Insurer Spending on Ivermectin Prescriptions for COVID-19 ja.ma/3zWrM70 via JAMA part of JAMA Network

Mitigating the Long-term Health Risks of Adverse Pregnancy Outcomes (could also be couched as mitigating sex disparities in CV health) ja.ma/33feR4c via JAMA part of JAMA Network

I found this fascinating. Extending Drug Monopolies by Patenting Safe Drug Use ja.ma/3J0yU5X via JAMA Internal Medicine part of JAMA Network

Gotta get the jersey on the wall, but it’s starting to shape up nicely in this office.

Lies, damned lies, and statistics. Seems both relative and absolute noninferiority margins are needed to address this issue. Consequences of Inaccurate Assumptions in Coronary Stent Noninferiority Trials ja.ma/3gz1cs0 via JAMA Cardiology part of JAMA Network

In short, pills don't negate the need for a healthy lifestyle. Lifestyle, Antihypertensive Medication, and Mortality Among Adults with Hypertension ja.ma/3oz7mg4 via JAMA Network Open part of JAMA Network

I know the proportion of guidelines supported by high quality RCTs is low, but examples are humbling. I took this as known. @jaccjournals jacc.org/doi/10.1016/j.…

🔑 Key Points from the "How to Deliver Care Driven by Data" session by Drs. Steve Bradley & Edward T.A. Fry and Kevin Willmann during the #CVSummit today

Attending #ACC22? Meet our cardiology editors at exhibit booth 1708: Karen Joynt Maddox , JAMA: Sat Apr 2, 10:15-11am Steve Bradley, JAMA Network Open: Sat Apr 2, 1-2pm Gbenga Ogedegbe, MD, JAMA Network Open: Sun Apr 3, 11:30am-12:30pm @bonowr, JAMA Cardiology: Sun Apr 3, 2:30-3pm

Attending #ACC22? JAMA Network Open editor Steve Bradley will be at booth 1708 in the exhibit hall today, Saturday, April 2, 1:00-2:00pm. Stop by to talk with him about your research and publishing opportunities with the JAMA Network

Full text behind a firewall, but my quick take between patients in clinic - this smells like confounding by indication. I would've thought bleeding a good falsification endpoint. Early Oral β-Blocker Therapy and Major Bleeding after PCI for ACS academic.oup.com/ehjqcco/advanc…

#TakeHeart app by ⁦Allina Health⁩ Minneapolis Heart Institute provides patient specific procedural instructions. I customized this one

I might limit myself to tweets along this vein for now on.

⁦Ty Gluckman⁩ and I comment on ISCHEMIA-EXTEND ahajournals.org/doi/10.1161/CI…

Differences between physician-reported and patient-reported health status (prior studies and Figure 2c here) anticipates this finding. NYHA Classification, Objective Measures of Heart Failure, and Long-term Prognosis ja.ma/3hd8F3R via JAMA Cardiology part of JAMA Network

Despite changing RF profile of🏥patients w COVID-19 to younger, less comorbidities⬇️rates of established CVD, incidence of reported CV complications of COVID-19⬆️driven by⬆️in stroke/MI suggests patients w COVID-19 in🏥remain at⬆️ risk CV morbidity/all ☠️ ahajournals.org/doi/10.1161/CI…